A*STAR Infectious Diseases (ID) Labs

Strategies and efforts in circumventing the emergence of antiviral resistance against conventional antivirals npj Antimicrobials and Resistance - Strategies and efforts in circumventing the emergence of antiviral resistance against conventional antivirals

Daryl and Denzel's BIG review of antiviral resistance in light of virus evolution. These two research officers worked a lot of nights and weekends to synthesise 300 references into a topic summary.

Click here for direct access to the article:
rdcu.be/ep9Wt

Frontiers | The role of periostin (OSF-2) in the cytoadherence phenomena mediated by malaria parasites IntroductionThe pathogenesis of severe malaria is primarily attributed to the cytoadherence properties of Plasmodium-infected erythrocytes (IRBC), which incl...

New study alert! Dr Wenn-Chyau Lee's group investigated the role of periostin (OSF-2) in the cytoadherence phenomena mediated by malaria parasites

www.frontiersin.org/journals/cel...

Lisa Ng: A Beacon of Innovation in Biomedical Research Curiosity often ignites the brightest minds, and for Lisa Ng, Executive Director of the Agency for Science, Technology and Research (A*STAR)’s Biomedical Research Council and A*STAR Infectious Disease...

Discover the inspiring journey of Prof. Lisa F.P. Ng, Executive Director of A*STAR’s BMRC & ID Labs, in CIO Views’ IWD special edition. Her passion, leadership & dedication drive groundbreaking infectious disease research. Read more! #IWD2025
cioviews.com/lisa-ng-a-be...

Computational model compares mpox's airborne transmission risk to COVID-19 and smallpox A collaborative research effort between the A*STAR Infectious Diseases Labs (A*STAR IDL) and the A*STAR Institute of High Performance Computing (A*STAR IHPC) has provided new insights into the likelih...

Computational modelling of Mpox's airborne transmission risk. Fantastic collaboration by Dr Matthew Tay and A*STAR IHPC. medicalxpress.com/news/2025-03...

Computational model compares mpox's airborne transmission risk to COVID-19 and smallpox A collaborative research effort between the A*STAR Infectious Diseases Labs (A*STAR IDL) and the A*STAR Institute of High Performance Computing (A*STAR IHPC) has provided new insights into the likelihood of mpox spreading by airborne respiratory particles, comparing it to SARS-CoV-2 and smallpox.

A computational model indicates that mpox's airborne transmission risk is significantly lower than that of COVID-19 and smallpox, though future viral evolution could change this dynamic. doi.org/g89m6w

Aerosol transmission risk of mpox relative to COVID-19 and smallpox - PubMed Aerosol transmission risk of mpox relative to COVID-19 and smallpox

Will mpox become an airborne respiratory pathogen like its now-eradicated relative, smallpox? Our researchers led by Dr Matthew Tay, in collaboration with #IHPC #A*STAR, conducted simulation modeling and found that mpox poses a much lower risk of becoming a true respiratory pathogen.